The Ministry of Health and Global health agency Unitaid have signed a memorandum of understanding that seeks to strengthen collaborative partnerships to advance global health goals.
Over its decade and a half history, Unitaid has worked closely with Kenyan partners to enable affordable, equitable, and rapid access to game-changing health innovations for those who need them.
These include early infant HIV diagnostics, best-in-class antiretroviral drugs for adults and children with HIV, child-friendly tuberculosis (TB) medicines, cutting-edge screen-and-treat solutions for cervical cancer, indoor sprays to curb malaria, and access to COVID-19 tests and medical oxygen, among many others.
Also Read: IEBC Meets The Four Presidential Candidates
The new agreement will improve alignment between Unitaid investments and Kenyan health priorities, enable early access to innovations, and strengthen the capacity of Kenyan health services, systems, research institutions, and manufacturers.
Joint efforts will focus on advancing sustainable approaches to reduce the burdens of HIV, TB, malaria, cervical cancer, hepatitis, COVID-19, improve the health of women and children, increase regional and domestic manufacturing of essential health products and strengthen pandemic preparedness and response efforts.